Gupta, Aditya K. http://orcid.org/0000-0002-8664-7723
Renaud, Helen J.
Quinlan, Emma M.
Shear, Neil H.
Piguet, Vincent
Article History
Accepted: 28 November 2020
First Online: 22 December 2020
Declarations
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: HJR and EMQ are employed by Mediprobe Research Inc., a not-for-profit, non-commercial research group and have no conflicts of interest that are directly relevant to the content of this article. AKG is a consultant for Bausch Health, Ortho Dermatologics, and Moberg Pharma; NHS has been a paid consultant to Alpha Laboratories, Canada & Bausch Health, Canada. VP has no personal financial ties with any pharmaceutical company. He undertakes advisory work for Pfizer, AbbVie, Janssen, UCB, Novartis, Almirall, and Celgene and has received honoraria from Kyowa Kirin Co., Ltd. In his role as Department Division Director of Dermatology at the University of Toronto, VP has received departmental support in the form of unrestricted educational grants from AbbVie, Bausch Health (formerly Valeant), Celgene, Janssen, LEO Pharma, Lilly, NAOS, Novartis, Pfizer, Pierre-Fabre, and Sanofi in the past 3 years.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: The manuscript was conceived by AKG; the work was drafted by HJR and substantively revised by AKG, EQ, NHS, and VP.